These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 571759)

  • 1. Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts.
    Beck WT; Mueller TJ; Tanzer LR
    Cancer Res; 1979 Jun; 39(6 Pt 1):2070-6. PubMed ID: 571759
    [No Abstract]   [Full Text] [Related]  

  • 2. Monoclonal antibodies to glycoproteins of Vinca alkaloid-resistant human leukemic cells.
    Danks MK; Metzger DW; Ashmun RA; Beck WT
    Cancer Res; 1985 Jul; 45(7):3220-4. PubMed ID: 3891080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continued expression of vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronase.
    Beck WT; Cirtain MC
    Cancer Res; 1982 Jan; 42(1):184-9. PubMed ID: 7198507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil.
    Beck WT; Cirtain MC; Look AT; Ashmun RA
    Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Vinca alkaloid acceptors in P388 murine leukemia cells with a photoactive analogue of vinblastine.
    Safa AR; Glover CJ; Felsted RL
    Cancer Res; 1987 Oct; 47(19):5149-54. PubMed ID: 3621200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface glycoproteins of rat lymphocytes. II. Protease-sensitive glycoproteins associated with mitogeni stimulation by periodate or neuraminidase plus galactose oxidase.
    Mitchell RN; Bowers WE
    J Immunol; 1980 Jun; 124(6):2632-40. PubMed ID: 6246168
    [No Abstract]   [Full Text] [Related]  

  • 7. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
    Beck WT; Cirtain MC; Lefko JL
    Mol Pharmacol; 1983 Nov; 24(3):485-92. PubMed ID: 6579344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukemia-associated antigen: relation to a family of surface glycoproteins.
    Pesando JM; Ritz J; Levine H; Terhorst C; Lazarus H; Schlossman SF
    J Immunol; 1980 Jun; 124(6):2794-9. PubMed ID: 6989907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts.
    Beck WT
    Cancer Treat Rep; 1983 Oct; 67(10):875-82. PubMed ID: 6354435
    [No Abstract]   [Full Text] [Related]  

  • 10. Differentiation and the multiple drug resistance phenotype in human leukemic cells.
    Beck WT; Cirtain MC; Ashmun RA; Mirro J
    Cancer Res; 1986 Sep; 46(9):4571-5. PubMed ID: 3015390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.
    Ramu A; Shan TC; Glaubiger D
    Cancer Treat Rep; 1983 Oct; 67(10):895-9. PubMed ID: 6354437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-resistance patterns and antigen expression in Vinca alkaloid- and other multiple drug-resistant human leukemic cell lines.
    Beck WT; Danks MK; Cirtain MC; van Heiningen JN
    Prog Clin Biol Res; 1986; 223():3-10. PubMed ID: 3468517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of colchicine and vinblastine on the intracellular migration of secretory and membrane glycoproteins: I. Inhibition of glycoprotein migration in various rat cell types as shown by light microscope radioautography after injection of 3H-fucose.
    Bennett G; Parsons S; Carlet E
    Am J Anat; 1984 Aug; 170(4):521-30. PubMed ID: 6475814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of membrane constituents in carcinomas and drug resistant tumour cells.
    Csuka O; Sugár J
    Arch Geschwulstforsch; 1978; 48(8):770-82. PubMed ID: 753197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of adhesion-related membrane components in adherent versus nonadherent hamster melanoma cells.
    Knudsen KA; Damsky CH; Buck CA
    J Cell Biochem; 1982; 18(2):157-67. PubMed ID: 7068778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells.
    Meyers MB; Rittmann-Grauer L; O'Brien JP; Safa AR
    Cancer Res; 1989 Jun; 49(12):3209-14. PubMed ID: 2566379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface glycoprotein patterns of human haematopoietic cell lines.
    Gahmberg CG; Andersson LC; Nilsson K
    IARC Sci Publ (1971); 1978; (24 Pt 2):649-53. PubMed ID: 221389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular resistance to vinblastine is associated with altered respiratory function.
    Wright LC; Dyne M; Holmes KT; Romeo T; Mountford CE
    Biochem Int; 1986 Aug; 13(2):295-305. PubMed ID: 3021161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-resistant mutants of Chinese hamster ovary cells possess an altered cell surface carbohydrate component.
    Juliano R
    J Supramol Struct; 1976; 4(4):521-6. PubMed ID: 933538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and late changes in the glycoproteins of Friend erythroleukemia cells induced to differentiate.
    Gazitt Y; Friend C
    Cancer Res; 1981 Mar; 41(3):1070-5. PubMed ID: 6936072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.